Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Splenic Diseases HELP
Based on 4,118 articles published since 2008
||||

These are the 4118 published articles about Splenic Diseases that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). 2015

Habib, Gilbert / Lancellotti, Patrizio / Antunes, Manuel J / Bongiorni, Maria Grazia / Casalta, Jean-Paul / Del Zotti, Francesco / Dulgheru, Raluca / El Khoury, Gebrine / Erba, Paola Anna / Iung, Bernard / Miro, Jose M / Mulder, Barbara J / Plonska-Gosciniak, Edyta / Price, Susanna / Roos-Hesselink, Jolien / Snygg-Martin, Ulrika / Thuny, Franck / Tornos Mas, Pilar / Vilacosta, Isidre / Zamorano, Jose Luis / Anonymous350841. · ·Eur Heart J · Pubmed #26320109.

ABSTRACT: -- No abstract --

2 Guideline General Gastroenterological Surgery: Spleen. 2015

Anonymous3710840. · ·Asian J Endosc Surg · Pubmed #26303729.

ABSTRACT: -- No abstract --

3 Guideline Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease. 2014

Marshall, John K / Otley, Anthony R / Afif, Waqqas / Bernstein, Charles N / Hookey, Lawrence / Leontiadis, Grigorios / Panaccione, Remo / Bressler, Brian / Anonymous3410804. · ·Can J Gastroenterol Hepatol · Pubmed #25157527.

ABSTRACT: -- No abstract --

4 Guideline Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia. 2014

Cornet, Edouard / Delmer, Alain / Feugier, Pierre / Garnache-Ottou, Francine / Ghez, David / Leblond, Véronique / Levy, Vincent / Maloisel, Frédéric / Re, Daniel / Zini, Jean-Marc / Troussard, Xavier / Anonymous3160799. ·Haematology Laboratory, Caen University Hospital, 14033, Caen Cedex, France. ·Ann Hematol · Pubmed #24994538.

ABSTRACT: Hairy cell leukaemia (HCL) is a rare haematological malignancy, with approximately 175 new incident cases in France. Diagnosis is based on a careful examination of the blood smear and immunophenotyping of the tumour cells, with a panel of four markers being used specifically to screen for hairy cells (CD11c, CD25, CD103 and CD123). In 2011, the V600E mutation of the BRAF gene in exon 15 was identified in HCL; being present in HCL, it is absent in the variant form of HCL (HCL-v) and in splenic red pulp lymphoma (SRPL), two entities related to HCL. The management of patients with HCL has changed in recent years. A poorer response to purine nucleoside analogues (PNAs) is observed in patients with more marked leukocytosis, bulky splenomegaly, an unmutated immunoglobulin variable heavy chain (IgVH) gene profile, use of VH4-34 or with TP53 mutations. We present the recommendations of a group of 11 experts belonging to a number of French hospitals. This group met in November 2013 to examine the criteria for managing patients with HCL. The ideas and proposals of the group are based on a critical analysis of the recommendations already published in the literature and on an analysis of the practices of clinical haematology departments with experience in managing these patients. The first-line treatment uses purine analogues: cladribine or pentostatin. The role of BRAF inhibitors, whether or not combined with MEK inhibitors, is discussed. The panel of French experts proposed recommendations to manage patients with HCL, which can be used in a daily practice.

5 Guideline [Prevention of severe infections in patients with hyposplenism or asplenia]. 2012

Lammers, A J Jolanda / van der Maas, Nicoline A T / Peters, Edgar J G / Meerveld-Eggink, Aafke / Sanders, E A M Lieke / Kroon, Frank P / Anonymous210741. ·Academisch Medisch Centrum, afd. Inwendige Geneeskunde, Amsterdam, the Netherlands. a.j.lammers@amc.uva.nl ·Ned Tijdschr Geneeskd · Pubmed #23114171.

ABSTRACT: Each year, up to a 1000 splenectomies are performed in the Netherlands. Aside from patients without a spleen, there is also a large group of patients with hyposplenism or functional asplenia due to other primary diseases. All these patients are at risk of developing severe infections, such as post-splenectomy sepsis (PSS), which is associated with very high mortality. However PSS can partly be prevented by taking simple measures such as immunizations and prophylactic or early use of antibiotics. Healthcare professionals in first and secondary care in the Netherlands are generally not well informed about which preventive measures should be taken to prevent these infections, resulting in often suboptimal management of patients. In this article, recommendations are given on vaccination and administration of antibiotics to prevent severe infections such as PSS in this group of patients.

6 Guideline Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: prepared on behalf of the British Committee for Standards in Haematology by a working party of the Haemato-Oncology task force. 2011

Davies, John M / Lewis, Michael P N / Wimperis, Jennie / Rafi, Imran / Ladhani, Shamez / Bolton-Maggs, Paula H B / Anonymous2640707. ·Western General Hospital, Crewe Road, Edinburgh, Manchester, UK. bcsh@b-s-h.org.uk ·Br J Haematol · Pubmed #21988145.

ABSTRACT: Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen were first published by the British Committee for Standards in Haematology (BCSH) in 1996 and formally reviewed in 2002. Although the guidelines originated from discussion within the BCSH, the intended readership is wide given the multidisciplinary nature of the management of hyposplenism.

7 Guideline Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). 2008

Habermalz, B / Sauerland, S / Decker, G / Delaitre, B / Gigot, J-F / Leandros, E / Lechner, K / Rhodes, M / Silecchia, G / Szold, A / Targarona, E / Torelli, P / Neugebauer, E. ·Institute for Research in Operative Medicine, University Witten/Herdecke, Witten/Herdecke, IFOM, Ostmerheimer Strasse 200, 51109, Köln, Germany. ·Surg Endosc · Pubmed #18293036.

ABSTRACT: BACKGROUND: Although laparoscopic splenectomy (LS) has become the standard approach for most splenectomy cases, some areas still remain controversial. To date, the indications that preclude laparoscopic splenectomy are not clearly defined. In view of this, the European Association for Endoscopic Surgery (EAES) has developed clinical practice guidelines for LS. METHODS: An international expert panel was invited to appraise the current literature and to develop evidence-based recommendations. A consensus development conference using a nominal group process convened in May 2007. Its recommendations were presented at the annual EAES congress in Athens, Greece, on 5 July 2007 for discussion and further input. After a further Delphi process between the experts, the final recommendations were agreed upon. RESULTS: Laparoscopic splenectomy is indicated for most benign and malignant hematologic diseases independently of the patient's age and body weight. Preoperative investigation is recommended for obtaining information on spleen size and volume as well as the presence of accessory splenic tissue. Preoperative vaccination against meningococcal, pneumococcal, and Haemophilus influenzae type B infections is recommended in elective cases. Perioperative anticoagulant prophylaxis with subcutaneous heparin should be administered to all patients and prolonged anticoagulant prophylaxis to high-risk patients. The choice of approach (supine [anterior], semilateral or lateral) is left to the surgeon's preference and concomitant conditions. In cases of massive splenomegaly, the hand-assisted technique should be considered to avoid conversion to open surgery and to reduce complication rates. The expert panel still considered portal hypertension and major medical comorbidities as contraindications to LS. CONCLUSION: Despite a lack of level 1 evidence, LS is a safe and advantageous procedure in experienced hands that has displaced open surgery for almost all indications. To support the clinical evidence, further randomized controlled trials on different issues are mandatory.

8 Editorial Asplenia and polysplenia syndromes: time of successful treatment and updated terminology. 2019

Thiene, Gaetano / Frescura, Carla. ·Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Italy. Electronic address: gaetano.thiene@unipd.it. · Department of Cardiac, Thoracic, and Vascular Sciences, University of Padua, Italy. ·Int J Cardiol · Pubmed #29980371.

ABSTRACT: -- No abstract --

9 Editorial The role of ketamine in addressing the anesthesia gap in low-resource settings. 2018

Suarez, Sebastian / Burke, Thomas F / Yusufali, Taha / Makin, Jennifer / Sessler, Daniel I. ·Division of Global Health and Human Rights, Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA. Electronic address: ssuarezzarate@mgh.harvard.edu. · Division of Global Health and Human Rights, Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA; African Institute for Health Transformation, Sagam Community Hospital, Luanda, Kenya; Harvard Medical School, Boston, MA, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA. · African Institute for Health Transformation, Sagam Community Hospital, Luanda, Kenya; College of Surgery for East, Central, and Southern Africa, Arusha, Tanzania. · Division of Global Health and Human Rights, Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard T.H. Chan School of Public Health, Boston, MA, USA. · Department of Outcomes Research, Anesthesiology Institute, Cleveland Clinic, Cleveland, OH, USA. ·J Clin Anesth · Pubmed #29885624.

ABSTRACT: -- No abstract --

10 Editorial The concept of "palliation" in children with heterotaxy syndrome. 2016

Cheung, Eva W / Bacha, Emile A. ·Division of Pediatric Cardiology, Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY. Electronic address: ec2335@cumc.columbia.edu. · Congenital and Pediatric Cardiac Surgery, Columbia University College of Physicians and Surgeons, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, NY. ·J Thorac Cardiovasc Surg · Pubmed #27085619.

ABSTRACT: -- No abstract --

11 Editorial Microwave Ablation for the Treatment of Hypersplenism: Short Waves, Low Cost, Big Results. 2016

Ha, Jonathan / Hendrix, Mack / Guyer, Adam G. ·Interventional Radiology, Department of Radiology, Hunter Holmes McGuire Veterans Administration Hospital, 1201 Broad Rock Blvd, Richmond, VA, 23249, USA. Jonathan.Ha@va.gov. · Interventional Radiology, Department of Radiology, Hunter Holmes McGuire Veterans Administration Hospital, 1201 Broad Rock Blvd, Richmond, VA, 23249, USA. ·Dig Dis Sci · Pubmed #26541991.

ABSTRACT: -- No abstract --

12 Editorial Neonates and isomerism: Are the rules different? 2015

Van Arsdell, Glen S. ·Department of Cardiovascular Surgery, Hospital for Sick Children, Toronto, Ontario, Canada. Electronic address: glen.vanarsdell@sickkids.on.ca. ·J Thorac Cardiovasc Surg · Pubmed #25956336.

ABSTRACT: -- No abstract --

13 Editorial New trends in ultrasound of hepatosplenic sarcoidosis. 2015

Tana, C / Silingardi, M / Dietrich, C F. ·Internal Medicine Unit, Guastalla Hospital, AUSL Reggio Emilia, Italy. · Innere Medizin 2, Caritas Krankenhaus Bad Mergentheim, Germany. ·Z Gastroenterol · Pubmed #25860577.

ABSTRACT: -- No abstract --

14 Editorial Can hypersplenism secondary to portal hypertension be treated by non-selective beta blockers? 2015

Kim, Moon Young / Iwakiri, Yasuko. ·Section of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA. ·Hepatol Int · Pubmed #25788189.

ABSTRACT: -- No abstract --

15 Editorial Scientific progress versus ecological influence on Schistosoma mansoni transmission. 2014

Jesus, Amélia Ribeiro de / Almeida, José Antônio Pacheco de. ·Departamento de Medicina, Laboratório de Biologia Molecular, Universidade Federal de Sergipe, Aracaju, SE, Brasil. · Departamento de Geografia, Universidade Federal de Sergipe, Acaraju, SE, Brasil. ·Rev Soc Bras Med Trop · Pubmed #24861283.

ABSTRACT: -- No abstract --

16 Editorial [A poorly known cause of peripartum hemorrhage]. 2013

Aya, A G M / Minville, V / Ripart, J. ·Division anesthésie-réanimation-douleur-urgence, faculté de médecine Montpellier-Nîmes, université Montpellier I, CHU Caremeau, place du Pr-Debré, 30029 Nîmes cedex 09, France. ·Ann Fr Anesth Reanim · Pubmed #24119789.

ABSTRACT: -- No abstract --

17 Editorial Nuclear factor-κB dysregulation in splenic marginal zone lymphoma: new therapeutic opportunities. 2012

Arcaini, Luca / Rossi, Davide. · ·Haematologica · Pubmed #22556352.

ABSTRACT: -- No abstract --

18 Editorial Impact of genetic diagnosis on clinical management of patients with congenital heart disease: cilia point the way. 2012

Brueckner, Martina. · ·Circulation · Pubmed #22499951.

ABSTRACT: -- No abstract --

19 Editorial Kawashima procedure: can pulmonary arteriovenous malformations be avoided? 2012

Vouhé, Pascal R. · ·Eur J Cardiothorac Surg · Pubmed #22345179.

ABSTRACT: -- No abstract --

20 Editorial Electromagnetic thermoablation to treat thrombocytopenia in cirrhotic and hypersplenic rats. 2010

Akahoshi, Tomohiko / Hashizume, Makoto. · ·J Gastroenterol Hepatol · Pubmed #20796139.

ABSTRACT: -- No abstract --

21 Editorial Splenic marginal zone lymphoma: hydra with many heads? 2010

Arcaini, Luca / Paulli, Marco. · ·Haematologica · Pubmed #20378575.

ABSTRACT: -- No abstract --

22 Editorial Hepatosplenic T-cell lymphoma and TNF-α inhibitors. 2009

Pozadzides, Jenny Vu / Pro, Barbara. · ·Expert Rev Hematol · Pubmed #21082951.

ABSTRACT: -- No abstract --

23 Editorial Clinical and biological diversity of splenic marginal zone lymphoma. 2009

Matutes, Estella. · ·Expert Rev Anticancer Ther · Pubmed #19761421.

ABSTRACT: -- No abstract --

24 Editorial Evidence-based analysis of the conclusion: what to do without a treatment algorithm. 2009

Goldin, Steven. · ·South Med J · Pubmed #19487991.

ABSTRACT: -- No abstract --

25 Review An extremely rare case of an oversized accessory spleen: case report and review of the literature. 2019

Palumbo, V / Mannino, M / Teodoro, M / Menconi, G / Schembari, E / Corsale, G / Di Carlo, I / Toro, A. ·Department of Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, Cannizzaro Hospital, Via Messina 829, 95126, Catania, Italy. · Department of Radiology, Cannizzaro Hospital, Catania, Italy. · Department of Surgical Sciences and Advanced Technologies "GF Ingrassia", University of Catania, Cannizzaro Hospital, Via Messina 829, 95126, Catania, Italy. idicarlo@unict.it. · Department of General Surgery, E. Muscatello Hospital, Augusta, (SR), Italy. ·BMC Surg · Pubmed #31029135.

ABSTRACT: BACKGROUND: The accessory spleen is a congenital defect characterized by a separated ectopic splenic parenchyma. The size is rarely more than 4 cm. The preoperative diagnosis is prohibitive preoperatively. The aims of the present manuscript were to present the case of a patient with a rare oversize accessory spleen and a review of the literature. CASE PRESENTATION: A 15-year-old boy was admitted to the emergency department following blunt abdominal trauma. The computed tomographic scan showed a traumatic rupture of the spleen and a 7-cm mass at the left side of the retroperitoneal space. Conservative treatment started and aborted after 4 h due to the onset of haemodynamic instability. Splenectomy was performed. An accessory spleen was discovered. A second large mass in the retroperitoneum was diagnosed as a second large accessory spleen that was also left in place. The postoperative course was uneventful, and the patient was discharged on the 7th postoperative day. Seven months later, the CT scan showed viability of both accessory spleens. CONCLUSION: An accessory spleen can be variously located and the retroperitoneal position is extremely uncommon. Preoperative diagnosis is still difficult, especially in emergency and as in our case, the literature shows the difficulty of reaching a diagnosis before surgery. The main misdiagnosis is neoplastic disease and for this reason accessory spleen can be wrongly removed. An undiagnosed pre or intra operative retroperitoneal mass, closely to the spleen, have to be managed carefully. The diagnosis of accessory spleen needs to be ever considered as if found, represents a great possibility to conduct a normal life after splenectomy (of main spleen) for trauma.

Next